BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 20437864)

  • 21. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).
    van den Heuvel-Eibrink MM; Wiemer EA; Prins A; Meijerink JP; Vossebeld PJ; van der Holt B; Pieters R; Sonneveld P
    Leukemia; 2002 May; 16(5):833-9. PubMed ID: 11986944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effect of bromocriptine and tumor necrosis factor-alpha on reversing hepatocellular carcinoma multidrug resistance in nude mouse MDR1 model of liver neoplasm.
    Ding L; Chen XP; Zhang ZW; Guan J; Zhang WG; Wang HP; Wang ZH; Li CL
    World J Gastroenterol; 2005 Sep; 11(36):5621-6. PubMed ID: 16237754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversing multidrug-resistant by RNA interference through silencing MDR1 gene in human hepatocellular carcinoma cells subline Bel-7402/ADM.
    Sheng L; Xiong M; Li C; Meng X
    Pathol Oncol Res; 2014 Jul; 20(3):541-8. PubMed ID: 24327315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
    Pérez-Tomás R
    Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
    Hu Y; Stephen AG; Cao J; Tanzer LR; Slapak CA; Harrison SD; Devanarayan V; Dantzig AH; Starling JJ; Rome LH; Moore RE
    Int J Cancer; 2002 Jan; 97(2):149-56. PubMed ID: 11774257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
    Beck JF; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
    Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Establishment of in vivo adriamycin-induced multidrug resistance models of subcutaneous and hepatic transplanted human liver cancer in nude mice].
    Zhai BJ; Wu F; Shao ZY; Hu K; Zhao CL; Wang ZB
    Ai Zheng; 2004 Aug; 23(8):905-9. PubMed ID: 15301712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound reverses multidrug resistance in human cancer cells by altering gene expression of ABC transporter proteins and Bax protein.
    Wu F; Shao ZY; Zhai BJ; Zhao CL; Shen DM
    Ultrasound Med Biol; 2011 Jan; 37(1):151-9. PubMed ID: 21084157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients.
    Rijavec M; Silar M; Triller N; Kern I; Cegovnik U; Košnik M; Korošec P
    Pathol Oncol Res; 2011 Sep; 17(3):691-6. PubMed ID: 21455636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
    Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
    Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
    Li G; Dong S; Qu J; Sun Z; Huang Z; Ye L; Liang H; Ai X; Zhang W; Chen X
    Liver Int; 2010 Apr; 30(4):585-92. PubMed ID: 19780956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of 7-
    Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y
    Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of HCC drug resistance by using hammerhead ribozymes against multidrug resistance 1 gene.
    Qia S; Wang H; Chen X
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):662-4. PubMed ID: 16696319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells.
    Chen XP; Wang Q; Guan J; Huang ZY; Zhang WG; Zhang BX
    World J Gastroenterol; 2006 Jun; 12(21):3332-7. PubMed ID: 16733848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age.
    van den Heuvel-Eibrink MM; van der Holt B; Burnett AK; Knauf WU; Fey MF; Verhoef GE; Vellenga E; Ossenkoppele GJ; Löwenberg B; Sonneveld P
    Ann Hematol; 2007 May; 86(5):329-37. PubMed ID: 17340137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear multidrug-resistance related protein 1 contributes to multidrug-resistance of mucoepidermoid carcinoma mainly via regulating multidrug-resistance protein 1: a human mucoepidermoid carcinoma cells model and Spearman's rank correlation analysis.
    Cai B; Miao Y; Liu Y; Xu X; Guan S; Wu J; Liu Y
    PLoS One; 2013; 8(8):e69611. PubMed ID: 24013781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel.
    Takara K; Obata Y; Yoshikawa E; Kitada N; Sakaeda T; Ohnishi N; Yokoyama T
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):785-93. PubMed ID: 16534613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of SCN5A overcomes ABC transporter-mediated multidrug resistance in acute myeloid leukemia through promoting apoptosis.
    Xu K; Zhuang XX; Shi XW
    Expert Rev Hematol; 2024; 17(1-3):87-94. PubMed ID: 38230679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.